Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices 19989 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–08521 Filed 4–13–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Infectious Diseases, BSC, OID 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 8:00 a.m.–5:00 p.m., 

EDT, May 6, 2015. 

Place: CDC, Global Communications 

Center, 1600 Clifton Road NE., Building 

19, Auditorium B3, Atlanta, Georgia 

30333. 

Status: The meeting is open to the 

public, limited only by the space 

available. 

Purpose: The BSC, OID, provides 

advice and guidance to the Secretary, 

Department of Health and Human 

Services; the Director, CDC; the 

Director, OID; and the Directors of the 

National Center for Immunization and 

Respiratory Diseases, the National 

Center for Emerging and Zoonotic 

Infectious Diseases, and the National 

Center for HIV/AIDS, Viral Hepatitis, 

STD, and TB Prevention, CDC, in the 

following areas: Strategies, goals, and 

priorities for programs; research within 

the national centers; and overall 

strategic direction and focus of OID and 

the national centers. 

Matters for Discussion: The meeting 

will include a report from the Food 

Safety Modernization Act Surveillance 

Working Group of the BSC, OID; brief 

updates on priority issues for CDC’s 

infectious disease programs; and 

updates and discussions on CDC’s 

Surveillance Strategy and the Global 

Health Security Agenda. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Robin Moseley, M.A.T., Designated 

Federal Officer, OID, CDC, 1600 Clifton 

Road NE., Mailstop D10, Atlanta, 

Georgia 30333, Telephone: (404) 639– 

4461. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–08518 Filed 4–13–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP); Initial Review 

The meeting announced below 

concerns Comparison and Validation of 

Screening Tools for Substance Use 

Among Pregnant Women, DP15–003, 

initial review. 

SUMMARY: This document corrects a 

notice that was published in the Federal 

Register on March 12, 2015 Volume 80, 

Number 48, page 13011. The times and 

dates should read as follows: 

Times and Dates: 9:00 a.m.–6:00 p.m., 

April 7–8, 2015 (Closed). 

FOR FURTHER INFORMATION CONTACT: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway NE., 

Mailstop F46, Atlanta, Georgia 30341, 

Telephone: (770)488–3585, EEO6@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–08519 Filed 4–13–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES (HHS) 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the following meeting for the 

aforementioned committee: 

Time and Date: 2:00 p.m.–3:00 p.m., 

EST, May 11, 2015. 

Place: This meeting will be accessible 

by teleconference. Toll-free +1 (888) 

790–1864, Participant Code: 5920580. 

Status: Open to the public limited 

only by the availability of telephone 

ports. 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion, the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters for Discussion: The agenda 

will include a follow up discussion on 

the Draft Guideline for the Prevention of 

Surgical Site Infections. Call materials 

will be made available to the public no 

later than 2 business days before the 

call. If CDC is unable to post the 

background material on the HICPAC site 

prior to the meeting, the background 

material will be posted on HICPAC’s 

Web site after the meeting. Background 

material is available at http://

www.cdc.gov/hicpac. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Erin Stone, M.S., HICPAC, Division of 

Healthcare Quality Promotion, NCEZID, 

CDC, 1600 Clifton Road NE., Mailstop 

A–31, Atlanta, Georgia 30333; Email: 

HICPAC@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 


asabaliauskas on DSK5VPTVN1PROD with NOTICES